Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000038777-25-000217
Filing Date
2025-11-04
Accepted
2025-11-04 11:25:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 22043
  Complete submission text file 0000038777-25-000217.txt   23873
Mailing Address ONE FRANKLIN PARKWAY SAN MATEO CA 94403
Business Address ONE FRANKLIN PARKWAY BUILDING 920/2, LEGAL-FRI SECRETARY SAN MATEO CA 94403 650-312-2000
FRANKLIN RESOURCES INC (Filed by) CIK: 0000038777 (see all company filings)

EIN.: 132670991 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465
Business Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 617-344-4190
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92677 | Film No.: 251447248
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)